[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Irritable Bowel Syndrome (IBS) Market Data Survey Report 2025

April 2018 | 73 pages | ID: G74E9E30BB3EN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

The global Irritable Bowel Syndrome (IBS) market will reach Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
  • Global market size and forecast
  • Regional market size, production data and export & import
  • Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
  • Major Application
  • Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
  • Valeant Pharmaceuticals
  • Allergan
  • Takeda
  • Sucampo Pharmaceuticals
  • McNeil Consumer Healthcare
  • Sebela Pharmaceuticals
  • Sebela Pharmaceuticals
  • IM HealthScience
Major applications as follows:
  • Women
  • Men
Major Type as follows:
  • IBS-D Drug
  • IBS-C Drug
  • Others
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Valeant Pharmaceuticals
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Allergan
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Takeda
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Sucampo Pharmaceuticals
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 McNeil Consumer Healthcare
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Sebela Pharmaceuticals
  3.6.1 Company Information
  3.6.2 Product Specifications
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Sebela Pharmaceuticals
  3.7.1 Company Information
  3.7.2 Product Specifications
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 IM HealthScience
  3.8.1 Company Information
  3.8.2 Product Specifications
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 MAJOR APPLICATION

4.1 Women
  4.1.1 Overview
  4.1.2 Women Market Size and Forecast
4.2 Men
  4.2.1 Overview
  4.2.2 Men Market Size and Forecast

5 MARKET BY TYPE

5.1 IBS-D Drug
  5.1.1 Overview
  5.1.2 IBS-D Drug Market Size and Forecast
5.2 IBS-C Drug
  5.2.1 Overview
  5.2.2 IBS-C Drug Market Size and Forecast
5.3 Others
  5.3.1 Overview
  5.3.2 Others Market Size and Forecast

6 CONCLUSION

LIST OF TABLES

Tab Regional Production 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Million USD)
Tab Sales Revenue, Cost and Margin of Valeant Pharmaceuticals
Tab Sales Revenue, Cost and Margin of Allergan
Tab Sales Revenue, Cost and Margin of Takeda
Tab Sales Revenue, Cost and Margin of Sucampo Pharmaceuticals
Tab Sales Revenue, Cost and Margin of McNeil Consumer Healthcare
Tab Sales Revenue, Cost and Margin of Sebela Pharmaceuticals
Tab Sales Revenue, Cost and Margin of Sebela Pharmaceuticals
Tab Sales Revenue, Cost and Margin of IM HealthScience

LIST OF FIGURES

Fig Global Irritable Bowel Syndrome (IBS) Market Size and CAGR 2011-2017 (Million USD)
Fig Global Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2018-2025 (Million USD)
Fig Women Market Size and CAGR 2011-2017 (Million USD)
Fig Women Market Forecast and CAGR 2018-2025 (Million USD)
Fig Men Market Size and CAGR 2011-2017 (Million USD)
Fig Men Market Forecast and CAGR 2018-2025 (Million USD)
Fig IBS-D Drug Market Size and CAGR 2011-2017 (Million USD)
Fig IBS-D Drug Market Forecast and CAGR 2018-2025 (Million USD)
Fig IBS-C Drug Market Size and CAGR 2011-2017 (Million USD)
Fig IBS-C Drug Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)


More Publications